US$ 21.31
obesity drug news today glp-1 2025 sep 30 The next phase of the race New weight-loss drugs surge in
Description
The magnitude of the benefits of GLP-1RA and SGLT-2 inhibitors on MACE are similar, ranging from 12 to 14% reduction of risk, but only GLP-1RA may reduce the risk of stroke

10.1038/s41598-017-19055-6 48

Chappuis, Genve (Mdecine des voyages)

RGC was reported in 20 out of 23 studies

Compared to the control group, Liraglutide reduced the risk of respiratory disease by 14% (RR 0.86, 95% CI 0.750.98, p = 0.03)

Searching for the most effective weight loss medication
